Professional Summary

Professional Overview

Leo Redmond is the Chief Financial Officer at Aulos Bioscience, a leading biopharmaceutical company focused on developing novel therapies for autoimmune and inflammatory diseases. With over 30 years of experience in the pharmaceutical and biotech industries, Redmond is a seasoned finance executive with a proven track record of driving strategic financial and operational initiatives.

Experience Summary

Current Role

As the Chief Financial Officer at Aulos Bioscience, Redmond is responsible for overseeing all financial, accounting, and risk management activities. He plays a crucial role in supporting the company's growth strategy, securing funding, and ensuring efficient financial operations. Under his leadership, Aulos Bioscience has successfully completed several financing rounds, enabling the advancement of its pipeline of promising drug candidates.

Career Progression

Prior to joining Aulos Bioscience, Redmond served as the Chief Financial Officer at Allakos Inc., where he led the company's successful IPO and managed its financial affairs during a period of significant expansion. Before that, he held the position of President and CFO at Presidio Pharmaceuticals, Inc., where he was instrumental in the company's strategic acquisitions and partnerships. Redmond's earlier experience includes serving as the CFO at Presidio Pharmaceuticals and holding a senior finance role at Genentech, a leading biopharmaceutical company.

Academic Background

Redmond holds a Bachelor of Science degree in Accounting from the University of California, Berkeley, and is a Certified Public Accountant (CPA).

Areas of Expertise

Redmond's areas of expertise include financial planning and analysis, capital markets, mergers and acquisitions, and strategic decision-making. He has a deep understanding of the pharmaceutical and biotechnology industries, having navigated complex regulatory environments and collaborated with key stakeholders throughout his career.

Professional Impact

Redmond's leadership and financial acumen have been instrumental in the growth and success of the organizations he has served. He has played a pivotal role in securing funding, driving operational efficiencies, and supporting the development of innovative therapies that have positively impacted patient lives.

Conclusion

With his extensive experience, strategic mindset, and track record of delivering results, Leo Redmond is a highly respected finance executive in the biopharmaceutical industry. As the Chief Financial Officer at Aulos Bioscience, he is poised to continue his contributions to the company's ongoing success and the advancement of transformative healthcare solutions.